Decreased Mitochondrial DNA Mutagenesis in Human Colorectal Cancer
Genome instability is regarded as a hallmark of cancer. Human tumors frequently carry clonally expanded mutations in their mitochondrial DNA (mtDNA), some of which may drive cancer progression and metastasis. The high prevalence of clonal mutations in tumor mtDNA has commonly led to the assumption that the mitochondrial genome in cancer is genetically unstable, yet this hypothesis has not been experimentally tested. In this study, we directly measured the frequency of non-clonal (random) de novo single base substitutions in the mtDNA of human colorectal cancers. Remarkably, tumor tissue exhibited a decreased prevalence of these mutations relative to adjacent non-tumor tissue. The difference in mutation burden was attributable to a reduction in C∶G to T∶A transitions, which are associated with oxidative damage. We demonstrate that the lower random mutation frequency in tumor tissue was also coupled with a shift in glucose metabolism from oxidative phosphorylation to anaerobic glycolysis, as compared to non-neoplastic colon. Together these findings raise the intriguing possibility that fidelity of mitochondrial genome is, in fact, increased in cancer as a result of a decrease in reactive oxygen species-mediated mtDNA damage.
Vyšlo v časopise:
Decreased Mitochondrial DNA Mutagenesis in Human Colorectal Cancer. PLoS Genet 8(6): e32767. doi:10.1371/journal.pgen.1002689
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002689
Souhrn
Genome instability is regarded as a hallmark of cancer. Human tumors frequently carry clonally expanded mutations in their mitochondrial DNA (mtDNA), some of which may drive cancer progression and metastasis. The high prevalence of clonal mutations in tumor mtDNA has commonly led to the assumption that the mitochondrial genome in cancer is genetically unstable, yet this hypothesis has not been experimentally tested. In this study, we directly measured the frequency of non-clonal (random) de novo single base substitutions in the mtDNA of human colorectal cancers. Remarkably, tumor tissue exhibited a decreased prevalence of these mutations relative to adjacent non-tumor tissue. The difference in mutation burden was attributable to a reduction in C∶G to T∶A transitions, which are associated with oxidative damage. We demonstrate that the lower random mutation frequency in tumor tissue was also coupled with a shift in glucose metabolism from oxidative phosphorylation to anaerobic glycolysis, as compared to non-neoplastic colon. Together these findings raise the intriguing possibility that fidelity of mitochondrial genome is, in fact, increased in cancer as a result of a decrease in reactive oxygen species-mediated mtDNA damage.
Zdroje
1. CairnsJ 1975 Mutation selection and the natural history of cancer. Nature 255 197 200
2. LoebLABielasJHBeckmanRA 2008 Cancers exhibit a mutator phenotype: clinical implications. Cancer Res 68 3551 3557; discussion 3557
3. WaiTTeoliDShoubridgeEA 2008 The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat Genet 40 1484 1488
4. HeYWuJDressmanDCIacobuzio-DonahueCMarkowitzSD 2010 Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464 610 614
5. CollerHAKhrapkoKBodyakNDNekhaevaEHerrero-JimenezP 2001 High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28 147 150
6. ArnoldRSSunCQRichardsJCGrigorievGColemanIM 2009 Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 69 1 11
7. IshikawaKTakenagaKAkimotoMKoshikawaNYamaguchiA 2008 ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320 661 664
8. BielasJHLoebLA 2005 Mutator phenotype in cancer: timing and perspectives. Environ Mol Mutagen 45 206 213
9. BielasJHLoebLA 2005 Quantification of random genomic mutations. Nat Methods 2 285 290
10. VermulstMBielasJHKujothGCLadigesWCRabinovitchPS 2007 Mitochondrial point mutations do not limit the natural lifespan of mice. Nat Genet 39 540 543
11. BielasJHLoebKRRubinBPTrueLDLoebLA 2006 Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A 103 18238 18242
12. SalkJJFoxEJLoebLA 2010 Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol 5 51 75
13. SiegmundKDMarjoramPTavareSShibataD 2009 Many colorectal cancers are “flat” clonal expansions. Cell Cycle 8 2187 2193
14. VogelsteinBFearonERHamiltonSRKernSEPreisingerAC 1988 Genetic alterations during colorectal-tumor development. N Engl J Med 319 525 532
15. WangDKreutzerDAEssigmannJM 1998 Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat Res 400 99 115
16. PolyakKLiYZhuHLengauerCWillsonJK 1998 Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20 291 293
17. LongleyMJNguyenDKunkelTACopelandWC 2001 The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J Biol Chem 276 38555 38562
18. LeeHRJohnsonKA 2006 Fidelity of the human mitochondrial DNA polymerase. J Biol Chem 281 36236 36240
19. JohnsonAAJohnsonKA 2001 Fidelity of nucleotide incorporation by human mitochondrial DNA polymerase. J Biol Chem 276 38090 38096
20. Vander HeidenMGCantleyLCThompsonCB 2009 Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 1029 1033
21. WarburgO 1956 On the origin of cancer cells. Science 123 309 314
22. BrandKAHermfisseU 1997 Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 11 388 395
23. Lopez-RiosFSanchez-AragoMGarcia-GarciaEOrtegaADBerrenderoJR 2007 Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res 67 9013 9017
24. YoshidaMMuneyukiEHisaboriT 2001 ATP synthase–a marvellous rotary engine of the cell. Nat Rev Mol Cell Biol 2 669 677
25. IsidoroAMartinezMFernandezPLOrtegaADSantamariaG 2004 Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J 378 17 20
26. JoseCBellanceNRossignolR 2011 Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 1807 552 561
27. OrtegaADSanchez-AragoMGiner-SanchezDSanchez-CenizoLWillersI 2009 Glucose avidity of carcinomas. Cancer Lett 276 125 135
28. ZelezniakAPersTHSoaresSPattiMEPatilKR 2010 Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS Comput Biol 6 e1000729
29. JonesRGThompsonCB 2009 Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 23 537 548
30. LevineAJPuzio-KuterAM 2010 The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330 1340 1344
31. LoebLASpringgateCFBattulaN 1974 Errors in DNA replication as a basis of malignant changes. Cancer Res 34 2311 2321
32. TomlinsonIBodmerW 1999 Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med 5 11 12
33. MarxJ 2002 Debate surges over the origins of genomic defects in cancer. Science 297 544 546
34. HarmanD 1956 Aging: a theory based on free radical and radiation chemistry. J Gerontol 11 298 300
35. JacobsHT 2003 The mitochondrial theory of aging: dead or alive? Aging Cell 2 11 17
36. HarmanD 1972 The biologic clock: the mitochondria? J Am Geriatr Soc 20 145 147
37. TaylorRWTaylorGADurhamSETurnbullDM 2001 The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res 29 E74 74
38. SalasAYaoYGMacaulayVVegaACarracedoA 2005 A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2 e296
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 6
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
Najčítanejšie v tomto čísle
- Rumors of Its Disassembly Have Been Greatly Exaggerated: The Secret Life of the Synaptonemal Complex at the Centromeres
- The NSL Complex Regulates Housekeeping Genes in
- Tipping the Balance in the Powerhouse of the Cell to “Protect” Colorectal Cancer
- Interplay between Synaptonemal Complex, Homologous Recombination, and Centromeres during Mammalian Meiosis